Hardy Reed LLC Purchases New Shares in Axon Enterprise, Inc. (NASDAQ:AXON)

Hardy Reed LLC purchased a new stake in shares of Axon Enterprise, Inc. (NASDAQ:AXON) during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor purchased 370 shares of the biotechnology company’s stock, valued at approximately $220,000.

A number of other hedge funds also recently bought and sold shares of AXON. Groupama Asset Managment purchased a new stake in Axon Enterprise during the third quarter valued at $200,000. Massachusetts Financial Services Co. MA purchased a new stake in Axon Enterprise during the third quarter valued at $120,553,000. International Assets Investment Management LLC purchased a new stake in Axon Enterprise during the third quarter valued at $871,860,000. Westfield Capital Management Co. LP raised its stake in Axon Enterprise by 12.2% during the third quarter. Westfield Capital Management Co. LP now owns 1,175,328 shares of the biotechnology company’s stock valued at $469,661,000 after purchasing an additional 127,769 shares in the last quarter. Finally, Assenagon Asset Management S.A. raised its stake in Axon Enterprise by 328.7% during the fourth quarter. Assenagon Asset Management S.A. now owns 145,299 shares of the biotechnology company’s stock valued at $86,354,000 after purchasing an additional 111,405 shares in the last quarter. Hedge funds and other institutional investors own 79.08% of the company’s stock.

Insider Buying and Selling at Axon Enterprise

In other Axon Enterprise news, insider Jeffrey C. Kunins sold 2,304 shares of the firm’s stock in a transaction dated Tuesday, December 3rd. The shares were sold at an average price of $654.79, for a total transaction of $1,508,636.16. Following the transaction, the insider now owns 128,542 shares of the company’s stock, valued at approximately $84,168,016.18. This trade represents a 1.76 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, Director Julie A. Cullivan sold 1,261 shares of the firm’s stock in a transaction dated Wednesday, December 4th. The shares were sold at an average price of $682.06, for a total transaction of $860,077.66. Following the transaction, the director now directly owns 2,392 shares in the company, valued at $1,631,487.52. This trade represents a 34.52 % decrease in their position. The disclosure for this sale can be found here. In the last quarter, insiders have sold 8,711 shares of company stock valued at $5,631,561. Company insiders own 6.10% of the company’s stock.

Analyst Upgrades and Downgrades

AXON has been the topic of a number of analyst reports. Northland Securities boosted their price objective on shares of Axon Enterprise from $365.00 to $550.00 and gave the company an “outperform” rating in a research report on Monday, November 11th. TD Cowen initiated coverage on shares of Axon Enterprise in a research report on Wednesday, January 8th. They set a “buy” rating and a $700.00 price objective on the stock. Robert W. Baird boosted their price objective on shares of Axon Enterprise from $600.00 to $800.00 and gave the company an “outperform” rating in a research report on Friday, December 6th. JMP Securities boosted their price objective on shares of Axon Enterprise from $610.00 to $725.00 and gave the company a “market outperform” rating in a research report on Tuesday, February 4th. Finally, Northcoast Research cut shares of Axon Enterprise from a “buy” rating to a “neutral” rating in a research report on Wednesday. Two analysts have rated the stock with a hold rating and fourteen have assigned a buy rating to the company’s stock. According to MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and a consensus price target of $542.15.

Axon Enterprise Trading Down 16.4 %

NASDAQ AXON opened at $593.42 on Thursday. The company has a debt-to-equity ratio of 0.32, a quick ratio of 2.63 and a current ratio of 2.96. The company has a market capitalization of $45.25 billion, a price-to-earnings ratio of 153.34, a price-to-earnings-growth ratio of 7.12 and a beta of 1.05. The company’s 50-day simple moving average is $624.50 and its two-hundred day simple moving average is $515.36. Axon Enterprise, Inc. has a one year low of $260.27 and a one year high of $715.99.

Axon Enterprise Company Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.